ask="1.89"
ask_size="1500"
average_daily_volume="227230"
bid="1.45"
bid_size="3000"
book_value="0.34"
change="-0.07"
change_from_200_day_moving_average="-0.26"
change_from_50_day_moving_average="-0.07"
change_from_52_week_high="-3.49"
change_From_52_week_low="0.50"
change_in_percent="-4.17%"
close="1.61"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="3761000"
high="1.74"
high_52_weeks="5.10"
last_trade_date="1/4/2017"
last_trade_price="1.61"
last_trade_size="169"
last_trade_time="4:00pm"
low="1.55"
low_52_weeks="1.11"
market_capitalization="15.43M"
moving_average_200_day="1.87"
moving_average_50_day="1.68"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="1.59"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-13.82%"
percent_change_from_50_day_moving_average="-4.22%"
percent_change_from_52_week_high="-68.43%"
percent_change_from_52_week_low="+45.05%"
previous_close="1.68"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.96"
price_per_sales="31.64"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.45"
stock_exchange="NCM"
symbol="EYEG"
volume="108747"
weeks_range_52="1.11 - 5.10"
